Update: Vinci To Buy 51% of SH1 Motorway near Hyderabad, India
VINCI acquires majority stake in an Indian motorway concession through subsidiary VINCI Highways.
Airbus Initiates A Share Buyback Program For Employee Ownership And Equity Compensation
Airbus begins share buyback program to support future employee ownership and compensation plans. The program will run until March 2025, purchasing up to…
AstraZeneca Make Important Change Breztri Inhalers used for treating COPD
AstraZeneca has made an important change to one of its inhalers, Breztri, used for treating COPD (a lung condition), by switching to a…
Update: Belgium’s Aedifica Invests £61.5M In 4 UK Care Homes
Aedifica NV/SA invested £61.5 million in 4 UK care homes, acquiring 3 existing ones and a future one. The press release details the…
Swiss Re Expects Rising Reinsurance Demand From Natural Disasters, Economic Instability
Swiss Re anticipates higher demand for reinsurance due to increased risks in property, specialty lines, and casualty, focusing on refined data, capital management,…
Update: Doctors Take More Than 1 Yr To Diagnose LGS in Kids – European Epilepsy Congress
New data from the 15th European Epilepsy Congress reveals significant delays in diagnosing Lennox-Gastaut syndrome (LGS) and its heavy disease burden.
Update: AstraZeneca Aims To Enhance Cancer Care At WCLC And ESMO 2024 Conferences
AstraZeneca shared results from a study showing TROP2 biomarker's predictive value in lung cancer patients treated with datopotamab deruxtecan. This biomarker was measured…
Update: Munich Re Sees Reinsurance Up Real 2-3% Mid-Term, High Demand, Risings Risks
Munich Re sees the market environment for reinsurers "promising and challenging at the same time", the company said at the “Rendez-Vous de Septembre”…
Update: Merck’s Ifinatamab Deruxtecan Shows Promise In Phase 2 Lung Cancer Trial
Merck & Co. reports Ifinatamab Deruxtecan shows promising response rates in Phase 2 IDeate-Lung01 trial for extensive-stage small cell lung cancer..
Update: Court Verdicts Propel 57% Increase in Claims Over the Last Decade – Swiss Re
Swiss Re's Social Inflation Index attributes the rise to large court verdicts, increased litigation funding, and legislative trends.